Characterization of TIM-3 Expression and Its Correlation with TNF- α and IFN- γ in Patients with Surgically Resected Lung Adenocarcinoma.
Disease Markers 2023
OBJECTIVE: T cell immunoglobulin and mucin-containing protein-3 (TIM-3) is an important immune checkpoint, but its role in lung cancer is still not clear. In this study, we investigated TIM-3 protein expression and its correlation with TNF- α and IFN- γ by examining the tissues of patients with lung adenocarcinoma.
METHODS: We detected the mRNA quantity of TIM-3, TNF- α , and IFN- γ in 40 surgically resected specimens from patients with lung adenocarcinoma by real-time quantitative polymerase chain reaction (qRT-PCR). The protein expression of TIM-3, TNF- α , and IFN- γ was assessed in normal tissues, paracarcinoma tissues, and tumor tissues by western blotting, respectively. The relevance between the expression and clinicopathological information of the patients was analyzed.
RESULTS: The results showed that the expression level of TIM-3 was higher in tumor tissues than normal tissues and paracancerous tissues ( P < 0.05). On the contrary, the expression of TNF- α and IFN- γ in tumor tissues was lower than normal tissues and paracarcinoma tissues ( P < 0.05). However, the expression levels of IFN- γ mRNA were not observed to be significantly different between cancerous tissues and adjacent tissues. While TIM-3 protein expression in cancer tissues of patients with lymph node metastasis was higher than in patients without metastasis, the expression of TNF- α and IFN- γ was lower ( P < 0.05). Importantly, the expression of TIM-3 was negatively correlated with the expression of TNF- α and IFN- γ , and the expression of TNF- α was found to be positively correlated with IFN- γ in the patient.
CONCLUSION: The high expression of TIM-3, the low expression of TNF- α and IFN- γ , and the synergistic effect of TNF- α and IFN- γ in patients with lung adenocarcinoma were closely related to poor clinicopathological characteristics. Overexpression of TIM-3 may play an important role in the relationship between TNF- α and IFN- γ secretion and poor clinicopathological characteristics.
METHODS: We detected the mRNA quantity of TIM-3, TNF- α , and IFN- γ in 40 surgically resected specimens from patients with lung adenocarcinoma by real-time quantitative polymerase chain reaction (qRT-PCR). The protein expression of TIM-3, TNF- α , and IFN- γ was assessed in normal tissues, paracarcinoma tissues, and tumor tissues by western blotting, respectively. The relevance between the expression and clinicopathological information of the patients was analyzed.
RESULTS: The results showed that the expression level of TIM-3 was higher in tumor tissues than normal tissues and paracancerous tissues ( P < 0.05). On the contrary, the expression of TNF- α and IFN- γ in tumor tissues was lower than normal tissues and paracarcinoma tissues ( P < 0.05). However, the expression levels of IFN- γ mRNA were not observed to be significantly different between cancerous tissues and adjacent tissues. While TIM-3 protein expression in cancer tissues of patients with lymph node metastasis was higher than in patients without metastasis, the expression of TNF- α and IFN- γ was lower ( P < 0.05). Importantly, the expression of TIM-3 was negatively correlated with the expression of TNF- α and IFN- γ , and the expression of TNF- α was found to be positively correlated with IFN- γ in the patient.
CONCLUSION: The high expression of TIM-3, the low expression of TNF- α and IFN- γ , and the synergistic effect of TNF- α and IFN- γ in patients with lung adenocarcinoma were closely related to poor clinicopathological characteristics. Overexpression of TIM-3 may play an important role in the relationship between TNF- α and IFN- γ secretion and poor clinicopathological characteristics.
Full text links
Trending Papers
2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association.Stroke; a Journal of Cerebral Circulation 2023 May 23
How to improve the efficiency and the safety of real-time ultrasound-guided central venous catheterization in 2023: a narrative review.Annals of Intensive Care 2023 May 26
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app